Orudis (Ketoprofen)

Ketoprofen, the active ingredient in Orudis, is a non‑steroidal anti‑inflammatory drug presented as a topical gel for dermal use. It relieves pain and inflammation associated with musculoskeletal conditions, osteoarthritis and soft‑tissue injuries in adults. GNH USA supplies Orudis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Ketoprofen acts on inflammatory pathways to provide analgesic and anti‑inflammatory effects in several musculoskeletal conditions. - Rheumatoid arthritis: reduces joint pain, swelling and stiffness. - Osteoarthritis: alleviates chronic joint discomfort and improves mobility. - Acute musculoskeletal injury: diminishes pain and inflammation following sprains, strains and bruises.

Ketoprofen may cause a range of adverse reactions, most of which are mild to moderate in severity.

Common Side Effects: - Skin irritation at application site: redness, itching or burning. - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness: transient light‑headedness.

Serious or Rare Side Effects: - Severe allergic reaction: hives, swelling, bronchospasm or anaphylaxis. - Ulceration or bleeding in the gastrointestinal tract. - Liver enzyme elevation or hepatic injury. - Renal impairment or acute kidney injury.

Ketoprofen should be used with caution: - Assess  "); - Assess  ");  ");  ...  "); -  ");  ...